Search Tag: drug development
2024 24 Sep
Randomised Controlled Trials (RCTs) are the gold standard for assessing drug efficacy, but they come with limitations, such as small sample sizes and highly controlled environments. On the other hand, real-world data (RWD) offer extensive datasets drawn from everyday medical practice, providing insights into larger populations. However, RWD lacks...Read more
2023 13 Jun
California-based start-up Varda Space Industries wants to capitalise on the potential of unassuming satellites in Earth's orbit for pharmaceutical development. The company intends to conduct space research and discover improved and more efficient drugs, ultimately generating substantial profits. Varda Space Industries successfully launched its...Read more
2023 13 Jun
California-based start-up Varda Space Industries wants to capitalise on the potential of unassuming satellites in Earth's orbit for pharmaceutical development. The company intends to conduct space research and discover improved and more efficient drugs, ultimately generating substantial profits. Varda Space Industries successfully launched its...Read more
2021 14 Jan
A new systematic review (Syeda et al. 2021) analyses artificial intelligence (AI) -based methods utilised to tackle the pandemic and provides insights into different COVID-19 themes. You might also like: AI Tool Helps to Reduce COVID-19 Mortality Since the onset of the COVID-19 pandemic, many healthcare organisations have...Read more
2015 06 Aug
6th August 2015, Basking Ridge, New Jersey; Dr Nader N Youssef, has been appointed Chief Medical Officer of electroCore, the US based electroceutical healthcare company. Nader brings more than 15 years of clinical, academic, and industry research experience to electroCore. He was previously Executive Director GI Global Clinical Development and...Read more
2015 18 Jun
According to the Cardiovascular Round Table (CRT), randomised controlled trials must be simplified to sustain innovation in cardiovascular diseases. CRT is an independent forum established by the European Society of Cardiology (ESC). The views of the group are published in the European Heart Journal . Professor Paulus Kirchhof, corresponding author,...Read more
2015 11 Feb
A group of researchers from Weill Cornell Medical College in New York City have devised a drug screen that capitalises on the tendency of toxic compounds to alter the properties of the lipid bilayer that encases cells. The method is to be presented at the 59th annual meeting of the Biophysical Society. As far as drug development is concerned,...Read more
2014 08 Nov
Key Points • Psychiatric drugs are among the most profitable products for the pharmaceutical industry. • Despite this, investment in psychiatric drug development continues to decline. • A major reason may be the fact that there has been no major breakthrough in this area of drug development for the last thirty years. • Several “me-too” products have...Read more
2014 01 Oct
According to new research from Thomson Reuters Bioworld, there are more than 700 follow-on biologic therapies currently in development. The new therapies are expected to generate approximately $100 billion in sales by the end of this decade. These projections demonstrate that the biopharmaceutical development industry is rapidly growing with...Read more